Trezac Arylex active efficacy trial

This Herbicide Matrix demonstration site was organized (hosted on 7th October 2020) by Elders and Nutrien Ag Solutions. Corteva was one of eight companies participating in the day to showcase new herbicide offerings coming to the market. Trezac Arylex active was the main focus from Corteva.

Key Outcomes:

  • Trezac at 200 mL/ha + Uptake (+/- Starane Advanced at 210 mL/ha + MCPA LVE) gave excellent control of chickpea and faba bean in a fallow scenario – the best post-emergent cereal herbicide for volunteer legume control seen at the field day.
  • The addition of MCPA LVE to Trezac was required for the control of volunteer canola.
  • When mixing Trezac with Axial there was no impact on broadleaf weed control. At this site the oats were treated at the first node stage, which is well outside of the Axial label treatment stage and as such the treatment gave poor grass control. Grass weeds should be no greater than first tiller stage when mixing Trezac with Axial Xtra. Other trial work has shown excellent compatibility of Trezac and Axial mixtures with no reduction in grass control compared to Axial alone.

Axial™ 100 EC herbicide is a trademark of Syngenta

More research trials...

Paradigm Late Season Mixes

Paradigm Arylex active late season mixes

This trial was sown in June 2020 and late applications were made in August & September. This trial highlights the flexibility of Paradigm Arylex active with different mix partners and at different growth stages with Paradigm alone.

View now
Rexade Mixing Partner

Rexade Arylex active Mixing Partner

This field trial was to demonstrate the compatibility of Rexade Arylex active when used with various mixing partners.

Sown in April 2020, treated August 2020.

View now
Rexade Water Rate

Rexade Arylex active droplet & water rate

This trial is to demonstrate Rexade Arylex active droplet spectrum, water rate & adjuvant testing.

Water rates of 75 L/ha and 100 L/ha were compared using three size nozzle types. Slow motion videos and water sensitivity paper show the effects of the trial.

View now